367 related articles for article (PubMed ID: 30443884)
1. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
2. Oral leukoplakia treatment with the carbon dioxide laser: A systematic review of the literature.
Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
J Craniomaxillofac Surg; 2016 Apr; 44(4):331-6. PubMed ID: 26920045
[TBL] [Abstract][Full Text] [Related]
3. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
[TBL] [Abstract][Full Text] [Related]
4. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery.
Yang SW; Lee YS; Chang LC; Yang CH; Luo CM
BMC Oral Health; 2021 Jan; 21(1):45. PubMed ID: 33509189
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of oral leukoplakia recurrence following CO₂ laser vaporization.
Chainani-Wu N; Lee D; Madden E; Sim C; Collins K; Silverman S
J Craniomaxillofac Surg; 2015 Nov; 43(9):1875-9. PubMed ID: 26364762
[TBL] [Abstract][Full Text] [Related]
6. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
7. The global prevalence of oral leukoplakia: a systematic review and meta-analysis from 1996 to 2022.
Zhang C; Li B; Zeng X; Hu X; Hua H
BMC Oral Health; 2023 Sep; 23(1):645. PubMed ID: 37670255
[TBL] [Abstract][Full Text] [Related]
8. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
9. Lesion characteristics and responses after CO2 laser vaporization in five patients With gingival leukoplakia.
Chainani-Wu N; Silverman S
J Calif Dent Assoc; 2013 Oct; 41(10):759-62, 765. PubMed ID: 24340428
[TBL] [Abstract][Full Text] [Related]
10. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
Li J; Liu Y; Zhang H; Hua H
Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606
[TBL] [Abstract][Full Text] [Related]
11. Treatment of oral leukoplakia with CO2 laser (10,600 nm): analysis of 37 cases.
Campos WG; Esteves CV; Gallo CB; Domaneschi C; Aranha ACC; Lemos CA
Braz Oral Res; 2022; 36():e014. PubMed ID: 35081231
[TBL] [Abstract][Full Text] [Related]
12. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up.
Del Corso G; Gissi DB; Tarsitano A; Costabile E; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Jul; 43(6):763-8. PubMed ID: 25979576
[TBL] [Abstract][Full Text] [Related]
13. Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients.
Yang SW; Lee YS; Chang LC; Hwang CC; Chen TA
Head Neck; 2020 May; 42(5):1014-1023. PubMed ID: 31930772
[TBL] [Abstract][Full Text] [Related]
14. CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation.
Jerjes W; Upile T; Hamdoon Z; Al-Khawalde M; Morcos M; Mosse CA; Hopper C
Lasers Med Sci; 2012 Jan; 27(1):169-79. PubMed ID: 21494890
[TBL] [Abstract][Full Text] [Related]
15. Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.
Luo R; Wang Y; Li R; Ma Y; Chen H; Zhang J; Shen J
BMC Oral Health; 2024 Apr; 24(1):469. PubMed ID: 38632580
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia.
Li F; Qiu L; Gao Q; Yu L; Liu H; Xue Z; Tao A
Genomics; 2023 Sep; 115(5):110686. PubMed ID: 37454941
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and malignant transformation of laryngeal leukoplakia treated with CO
Sun K; Wang C; Gong S; Zhang H; Zhang S; Hu H; Lu Y; Liu K; Yu Z
Clin Otolaryngol; 2024 Apr; ():. PubMed ID: 38558499
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation rate of oral leukoplakia in an Australian population.
Shearston K; Fateh B; Tai S; Hove D; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563
[TBL] [Abstract][Full Text] [Related]
19. Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery.
Bagan J; Martorell M; Cebrián JL; Rubert A; Bagán L; Mezquida C; Hervás D
Clin Oral Investig; 2022 Aug; 26(8):5181-5188. PubMed ID: 35474554
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO
Galletta V; Azevedo L; Lodi G; Migliari D
J Contemp Dent Pract; 2017 Sep; 18(9):775-780. PubMed ID: 28874640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
